176 related articles for article (PubMed ID: 38214842)
1. Association Between Diverse Cell Death Patterns Related Gene Signature and Prognosis, Drug Sensitivity, and Immune Microenvironment in Glioblastoma.
Li J; Song Z; Chen Z; Gu J; Cai Y; Zhang L; Wang Z
J Mol Neurosci; 2024 Jan; 74(1):10. PubMed ID: 38214842
[TBL] [Abstract][Full Text] [Related]
2. Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery.
Zou Y; Xie J; Zheng S; Liu W; Tang Y; Tian W; Deng X; Wu L; Zhang Y; Wong CW; Tan D; Liu Q; Xie X
Int J Surg; 2022 Nov; 107():106936. PubMed ID: 36341760
[TBL] [Abstract][Full Text] [Related]
3. Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns.
Wei Q; Jiang X; Miao X; Zhang Y; Chen F; Zhang P
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11351-11368. PubMed ID: 37378675
[TBL] [Abstract][Full Text] [Related]
4. Systematic analysis based on the cuproptosis-related genes identifies ferredoxin 1 as an immune regulator and therapeutic target for glioblastoma.
Dai L; Zhou P; Lyu L; Jiang S
BMC Cancer; 2023 Dec; 23(1):1249. PubMed ID: 38114959
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma.
Bi Y; Wu ZH; Cao F
BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019
[TBL] [Abstract][Full Text] [Related]
6. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
[TBL] [Abstract][Full Text] [Related]
7. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
8.
Liang L; Yan B; Liu Y; Jiang S; He H; Huang J; Liu W; Xie L
Dis Markers; 2022; 2022():4534080. PubMed ID: 35401877
[TBL] [Abstract][Full Text] [Related]
9. Construction and validation of a cuproptosis-related prognostic model for glioblastoma.
Zhang B; Xie L; Liu J; Liu A; He M
Front Immunol; 2023; 14():1082974. PubMed ID: 36814929
[TBL] [Abstract][Full Text] [Related]
10. Combined bulk RNA-seq and single-cell RNA-seq identifies a necroptosis-related prognostic signature associated with inhibitory immune microenvironment in glioma.
Wan S; Moure UAE; Liu R; Liu C; Wang K; Deng L; Liang P; Cui H
Front Immunol; 2022; 13():1013094. PubMed ID: 36466844
[TBL] [Abstract][Full Text] [Related]
11. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
Huang QR; Li JW; Pan XB
Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
[TBL] [Abstract][Full Text] [Related]
12. Identification and analysis of diverse cell death patterns in diabetic kidney disease using microarray-based transcriptome profiling and single-nucleus RNA sequencing.
Luo Y; Liu L; Zhang C
Comput Biol Med; 2024 Feb; 169():107780. PubMed ID: 38104515
[TBL] [Abstract][Full Text] [Related]
13. Leveraging diverse cell-death patterns to predict the clinical outcome of immune checkpoint therapy in lung adenocarcinoma: Based on muti-omics analysis and vitro assay.
Liang H; Li Y; Qu Y; Zhang L
Oncol Res; 2023; 32(2):393-407. PubMed ID: 38186574
[TBL] [Abstract][Full Text] [Related]
14. Tetraspanins predict the prognosis and characterize the tumor immune microenvironment of glioblastoma.
Li YC; Wu Y; Chen G; Zhu LZ; Luo X; Nie QQ; Zhang L; Zuo CJ
Sci Rep; 2023 Aug; 13(1):13317. PubMed ID: 37587203
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of oxidative stress-related lncRNA signatures in glioma reveals the discrepancy of prognostic and immune infiltration.
Shi Z; Wu Y; Zhuo Q; Zuo Y; Lin J; Shi H; Zhou H; Xu Z
Sci Rep; 2023 May; 13(1):7731. PubMed ID: 37173373
[TBL] [Abstract][Full Text] [Related]
16. Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma.
Zeng Y; Cai Y; Chai P; Mao Y; Chen Y; Wang L; Zeng K; Zhan Z; Xie Y; Li C; Zhan H; Zhao L; Chen X; Zhu X; Liu Y; Chen M; Song Y; Zhou A
Front Immunol; 2022; 13():961933. PubMed ID: 35990696
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel autophagy-related prognostic signature and small molecule drugs for glioblastoma by bioinformatics.
Wang D; Jiang Y; Wang T; Wang Z; Zou F
BMC Med Genomics; 2022 May; 15(1):111. PubMed ID: 35550147
[TBL] [Abstract][Full Text] [Related]
18. The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma.
Wang W; Lu Z; Wang M; Liu Z; Wu B; Yang C; Huan H; Gong P
Front Immunol; 2022; 13():998236. PubMed ID: 36110851
[TBL] [Abstract][Full Text] [Related]
19. Development of a prognostic model for glioblastoma multiforme based on the expression levels of efferocytosis-related genes.
Xu W; Han L; Zhu P; Cheng Y; Chen X
Aging (Albany NY); 2023 Dec; 15(24):15578-15598. PubMed ID: 38159261
[TBL] [Abstract][Full Text] [Related]
20. A Novel Glucose Metabolism-Related Gene Signature for Overall Survival Prediction in Patients with Glioblastoma.
Zhang C; Wang M; Ji F; Peng Y; Wang B; Zhao J; Wu J; Zhao H
Biomed Res Int; 2021; 2021():8872977. PubMed ID: 33553434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]